Glaxosmithkline | GSK - Ordinary Share Capital

Stock Price
54.44
Daily Change
-4.68 -7.92%
Monthly
-8.13%
Yearly
45.44%
Q2 Forecast
53.52

Glaxosmithkline reported GBP4.08B in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Amgen USD 539M 1000K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
Aurora Cannabis CAD 56.71M 134.13K Dec/2025
Bausch Health Companies USD 370.53M 59K Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Canopy Growth CAD 368.28M 35.9M Dec/2025
Corcept Therapeutics USD 105.97M 842K Dec/2025
Drreddys Laboratories INR 832.57M 53K Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Glaxosmithkline GBP 4.08B 49.43M Dec/2025
J&J USD 2.41B 1.74M Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Novartis USD 1.91B 10.64M Dec/2025
Pacira USD 41.12M 1.85M Dec/2025
Perrigo USD 137.6M 0 Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
Phibro Animal Health USD 40.48M 0 Dec/2025
Prestige Brands USD 48.08M 47.52M Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Sanofi EUR 1.21B 8.25M Mar/2026
Supernus Pharmaceuticals USD 57.12M 1000K Sep/2025
Takeda JPY 1.58B 2K Dec/2025
Teva Pharmaceutical Industries USD 1.15B 0 Dec/2025
Zoetis USD 424.93M 16.54M Dec/2025